Financial statements Nephrolab Plus
Balance sheet of Nephrolab Plus
Company age:
Age:
6 y. 11 m. 16 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NEPHROLAB PLUS
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 032,60 | 597 518,65 | 360,97 | 39,03 | 210,97 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 1 032,60 | 597 518,65 | 360,97 | 39,03 | 210,97 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 1 032,60 | 597 518,65 | 360,97 | 39,03 | 210,97 |
| A. Equity | 1 032,60 | 1 614,21 | -28 478,83 | -36 618,43 | -42 920,35 |
| B. Liabilities and provisions for liabilities | 0,00 | 595 904,44 | 28 839,80 | 36 657,46 | 43 131,32 |
| I. Long-term liabilities | 0,00 | - | - | - | - |
| II. Short-term liabilities | 0,00 | 3 058,44 | 28 839,80 | 36 657,46 | 43 131,32 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.